Panel Discussion

Saturday, March 8, 2025

2:37 PM – 3:00 PM ET

Panel Moderator(s)

Robert M. Bersin, MD, MPH, FSCAI

Medical Director, Endovascular Services
Swedish Heart and Vascular (Emeritus)
Parc de la Baie Orientale, France

Disclosure(s): Nectero, Inc.: Stock-privately held company (Ongoing)

Panel Discussant(s)

Nimesh Desai, MD

Associate Professor
Hospital of the University of Pennsylvania

Disclosure(s): Edwards Lifesciences: Consultant (Ongoing), Grant/Research Support (Ongoing); WL Gore & Associates: Consultant (Ongoing), Grant/Research Support (Ongoing)
Hans R. Figulla, MD, PhD

Full Professor emeritus
Universitätsklinikum Jena
Jena, Thuringen, Germany

Disclosure(s): devie medical GmbH: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); P&F GmbH, Vienna: License (Ongoing)
Dipankar Mukherjee, MD

chief of vascular surgery
INOVA Fairfax Hospital
Vienna, Virginia, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Robert M. Bersin, MD, MPH, FSCAI: Nectero, Inc.: Stock-privately held company (Ongoing)

Nimesh Desai, MD: Edwards Lifesciences: Consultant (Ongoing), Grant/Research Support (Ongoing); WL Gore & Associates: Consultant (Ongoing), Grant/Research Support (Ongoing)

Hans R. Figulla, MD, PhD: devie medical GmbH: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); P&F GmbH, Vienna: License (Ongoing)

Dipankar Mukherjee, MD: No financial relationships to disclose